Skip to main content
. 2022 May 18;9:884446. doi: 10.3389/fmed.2022.884446

Figure 2.

Figure 2

Identified NTM species percentages. (A) Total suspected NTM patients (n = 480). (B) Diagnosed NTM infections in immunocompetent patients (n = 54). (C) Diagnosed NTM infections in immunocompromised patients (n = 64).